Laurus Labs informs about company updates

19 Aug 2017 Evaluate

Laurus Labs has informed that US Food and Drug Administration (USFDA) has completed inspection of API facilities in Unit 1 and 3 in Parawada, Visakhapatnam, Andhra Pradesh, with two observations. This is a regular surveillance audit by USFDA, and the observations are procedural in nature and no data integrity issues were observed.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

491.90 6.75 (1.39%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.